home / stock / bmra / bmra news


BMRA News and Press, Biomerica Inc. From 10/01/21

Stock Information

Company Name: Biomerica Inc.
Stock Symbol: BMRA
Market: NASDAQ
Website: biomerica.com

Menu

BMRA BMRA Quote BMRA Short BMRA News BMRA Articles BMRA Message Board
Get BMRA Alerts

News, Short Squeeze, Breakout and More Instantly...

BMRA - BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biomerica (NASDAQ: BMRA ) stock is surging higher on Friday thanks to a new deal with Walmart (NYSE: WMT ) concerning its EZ Detect product. Source: Jonathan Weiss / Shutterstock.com A news release from...

BMRA - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! The final day of the workweek is here and with it comes a look at the pre-market stock movers for Friday! Source: Shutterstock Moving shares today are BTC prices rising, a reverse stock split...

BMRA - Walmart Now Selling Biomerica's EZ Detect(TM) Colorectal Screening Test

Simple 2 minute at-home test detects early warning sign of colorectal cancer IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that it has entered into a General Merchandise Supplier Agreement with Wa...

BMRA - Corvus Pharmaceuticals, Innate Pharma lead healthcare gainers; Protagonist Therapeutics, TCR2 Therapeutics among major losers

Gainers: Corvus Pharmaceuticals (NASDAQ:CRVS) +73%, Innate Pharma IPHA +51%, SmileDirectClub (NASDAQ:SDC) +12%, Biomerica (NASDAQ:BMRA) +9%, I-Mab (NASDAQ:IMAB) +6%. Losers: Protagonist Therapeutics PTGX -62%, TCR2 Therapeutics TCRR -31%,...

BMRA - Is Biomerica Stock A Buy Or Sell After Q4 Earnings? Catalysts To Watch Into 2022

Biomerica recently reported its fiscal 2021 Q4 results highlighted by key product updates supporting a positive long-term outlook. The company's irritable bowel syndrome "IBS" diagnostic therapy technology platform continues to move towards an FDA approval representing a significant g...

BMRA - Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week

Final patients to compete this double blinded trial by end of October. Top-Line trial results expected by year end. The InFoods ® IBS Diagnostic-Guided Therapy is the first therapy of its kind for treating all forms of IBS. InFoods ® IBS product...

BMRA - Biomerica Reports Fiscal 2021 Year End Results

Revenues increase 7.6% for fiscal 2021 vs fiscal 2020. InFoods ® IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks. Biomerica receives multiple notices of allowance for patents covering the InFoods® Technology Platform provid...

BMRA - Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression

Hundreds of millions of people worldwide suffer from depression IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica’s first patent pertaining to a ...

BMRA - Biomerica Launches New Website For Its EZ Detect(TM) Colorectal Disease Screening Test

Digital Health Advertising and Social Media Campaigns launching alongside new site Currently in discussion with major retailers to increase distribution of EZ Detect™ Colon Disease Test IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ...

BMRA - 50+ Companies to Present at the Access to Giving Virtual Investor Conference on July 13th - 15th, 2021

RALEIGH, NC / ACCESSWIRE / July 8, 2021 / Access to Giving - an investor conference themed around investor education and advocacy begins next week, July 13 th - 15 th , 2021. More than 50 companies are scheduled to conduct virtual presentations over the three-day period as well as 1x1 meeti...

Previous 10 Next 10